Cargando…
The combined activation of K(Ca)3.1 and inhibition of K(v)11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
BACKGROUND: Platinum-based drugs such as Cisplatin are commonly employed for cancer treatment. Despite an initial therapeutic response, Cisplatin treatment often results in the development of chemoresistance. To identify novel approaches to overcome Cisplatin resistance, we tested Cisplatin in combi...
Autores principales: | Pillozzi, Serena, D'Amico, Massimo, Bartoli, Gianluca, Gasparoli, Luca, Petroni, Giulia, Crociani, Olivia, Marzo, Tiziano, Guerriero, Angela, Messori, Luigi, Severi, Mirko, Udisti, Roberto, Wulff, Heike, Chandy, K George, Becchetti, Andrea, Arcangeli, Annarosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785745/ https://www.ncbi.nlm.nih.gov/pubmed/29161243 http://dx.doi.org/10.1038/bjc.2017.392 |
Ejemplares similares
-
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
por: Crociani, Olivia, et al.
Publicado: (2013) -
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020) -
The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022) -
Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020) -
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
por: Pillozzi, S, et al.
Publicado: (2016)